Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27658870)

Published in Lancet HIV on August 31, 2016

Authors

Monica Gandhi1, David V Glidden2, Kenneth Mayer3, Mauro Schechter4, Susan Buchbinder5, Beatriz Grinsztejn6, Sybil Hosek7, Martin Casapia8, Juan Guanira9, Linda-Gail Bekker10, Alexander Louie11, Howard Horng12, Leslie Z Benet12, Albert Liu13, Robert M Grant14

Author Affiliations

1: Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: monica.gandhi@ucsf.edu.
2: Department of Biostatistics and Epidemiology, University of California, San Francisco, San Francisco, CA, USA.
3: Fenway Health, Boston, MA, USA.
4: Projeto Praça Onze, Hospital Escola Sâo Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
5: San Francisco Department of Public Health, San Francisco, CA, USA.
6: Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio De Janeiro, Brazil.
7: Department of Psychiatry, Stroger Hospital of Cook County, Chicago, IL, USA.
8: Asociacion Civil Selva Amazonica (ACSA) CRS, Iquitos, Peru.
9: Investigaciones Médicas en Salud, Lima, Peru.
10: Desmond Tutu Health Foundation, Faculty of Health Sciences, Cape Town, South Africa.
11: Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
12: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
13: HIV Prevention Intervention Studies Bridge HIV, San Francisco, CA, USA.
14: Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, CA, USA.

Associated clinical trials:

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men | NCT00458393

Articles cited by this

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28

Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med (2012) 6.29

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis (2014) 5.59

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med (2015) 4.26

Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr (2006) 3.93

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis (2013) 3.04

Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65

Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial. JAMA Intern Med (2015) 2.35

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses (2012) 1.89

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis (2015) 1.76

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV (2015) 1.61

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS One (2014) 1.35

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS (2014) 1.34

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS (2010) 1.24

Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration. Antivir Ther (2014) 1.00

Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012. Clin Infect Dis (2014) 0.99

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med (2015) 0.97

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring. J Infect Dis (2015) 0.94

Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Expert Opin Drug Saf (2015) 0.85

The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort. J Int AIDS Soc (2014) 0.81

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients. J Acquir Immune Defic Syndr (2016) 0.80

Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr (2016) 0.80

Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (2016) 0.78